The safety of extended-release drug formulations for the treatment of ADHD

  • Ann Childress
  • Expert Opinion on Drug Safety, May 2017, Taylor & Francis
  • DOI: 10.1080/14740338.2017.1317344

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/14740338.2017.1317344